Harvard Business Review

MAY 2, 2011

As multinational corporations pursue opportunities in emerging markets, they're bound to stumble if they overlook the developed economies, and vice versa. Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies.

Globalization 13

Globalization Marketing Venture Capitalist Biotechnology 13

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 26, 2011

Many venture capitalists are limiting their investments to the "demand-side" — aimed at reducing energy use — rather than investing in startups trying to change the way we produce energy. Their behavior displays promising parallels to the early days of the biotechnology industry.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. “But here, we can operate within the time frame of the next coffee break.” Profit-driven companies, on the other hand, feel so much pressure to go to market that they often pass on ideas with vast potential.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 3, 2015

Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. Get in touch with a venture capitalist. Learn more about your market value. He then mapped out the network of who consulted with whom. Start a blog.

How To 8

How To Diversity Letter Learning-by-Doing 8